Study of CHO-A04 in Advanced Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2028

Conditions
Advanced Solid Tumors
Interventions
DRUG

CHO-A04

CHO-A04 will be given intravenously (IV) once weekly for 4 weeks as a treatment cycle.

Trial Locations (1)

10002

Department of Oncology, National Taiwan University Hospital, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cho Pharma Inc.

INDUSTRY